| Tue, Jul 7, 2009 | | • | Zacks #5 Rank Additions for Tuesday
Zacks.com (Tue, Jul 7)
| | Mon, Jul 6, 2009 | | • | Lilly Shows Us How It's Done
at Motley Fool (Mon, Jul 6)
| | Thu, Jul 2, 2009 | | • | Coverage initiated on Onyx Pharma by Robert W. Baird
Briefing.com (Thu, Jul 2)
| | Wed, Jul 1, 2009 | | • | Cost-Effectiveness of Cancer Drugs Is Questioned
at The Wall Street Journal Online (Wed, Jul 1)
| | • | Pharmaceutical Dollar Rationing by Results
at Seeking Alpha (Wed, Jul 1)
| | Tue, Jun 30, 2009 | | • | Biotech Calendar: Key Clinical Trial Dates
at TheStreet.com (Tue, Jun 30)
| | Fri, Jun 26, 2009 | | • | 4-Star Stocks on the Upswing
at Motley Fool (Fri, Jun 26)
| | Thu, Jun 25, 2009 | | • | Pfizer Gets a Double
at Motley Fool (Thu, Jun 25)
| | Wed, Jun 24, 2009 | | • | [$$] Get Ready to Sell a Bounce
at RealMoney by TheStreet.com (Wed, Jun 24)
| | Fri, Jun 19, 2009 | | • | Dendreon Is No Dot-Com Story ... Yet
at Motley Fool (Fri, Jun 19)
| | • | A Meaningless FDA Approval ... for Now
at Motley Fool (Fri, Jun 19)
| | Thu, Jun 18, 2009 | | • | Is Dendreon Just a Dot-Com Story at This Price?
at Motley Fool (Thu, Jun 18)
| | Wed, Jun 10, 2009 | | • | Here's Your Shot to Score Big
at Motley Fool (Wed, Jun 10)
| | Wed, Jun 3, 2009 | | • | Keryx: Another Beneficiary of the ASCO Effect
at Seeking Alpha (Wed, Jun 3)
| | Tue, Jun 2, 2009 | | • | Onyx Pharmaceuticals to Present at the Goldman Sachs 30th Annual Global Healthcare Conference
PR Newswire (Tue, Jun 2)
| | Mon, Jun 1, 2009 | | • | Bayer and Onyx Initiate Phase 3 Trial of Nexavar in Non-Small Cell Lung Cancer
PR Newswire (Mon, Jun 1)
| | Sat, May 30, 2009 | | • | [$$] Roche's Avastin Fails in Early Colon Cancer
at The Wall Street Journal Online (Sat, May 30)
| | Fri, May 29, 2009 | | • | [$$] Onyx Pharmaceuticals on Track for Growth
at Barron's Online (Fri, May 29)
| | Thu, May 28, 2009 | | • | Make Money, Fight Disease: The ASCO Preview
at Motley Fool (Thu, May 28)
| | • | Onyx rises as analyst starts coverage at 'Buy'
AP (Thu, May 28)
|
Add ONXX News to My Yahoo!:
 
| |
|
0.06% Nasdaq 0.00%
Headlines
